Search

Jarolim, P, J Palek, T L Coetzer, J Lawler, E Velez-Garcia, J Fradera, A Charles, H S Jacob, and J L Moake. 1989. “Severe Hemolysis and Red Cell Fragmentation Caused by the Combination of a Spectrin Mutation With a Thrombotic Microangiopathy.”. American Journal of Hematology 32 (1): 50-6.

Ketis, N, V, J Lawler, R L Hoover, and M J Karnovsky. 1988. “Effects of Heat Shock on the Expression of Thrombospondin by Endothelial Cells in Culture.”. The Journal of Cell Biology 106 (3): 893-904.

Coetzer, T, J Lawler, J T Prchal, and J Palek. 1987. “Molecular Determinants of Clinical Expression of Hereditary Elliptocytosis and Pyropoikilocytosis.”. Blood 70 (3): 766-72.

Sloand, E M, D M Kenney, F C Chao, J Lawler, and J L Tullis. 1987. “Platelet Antithrombin Defect in Malignancy: Platelet Protein Alterations.”. Blood 69 (2): 479-85.

Dainiak, N, S Kreczko, A Cohen, R Pannell, and J Lawler. 1985. “Primary Human Marrow Cultures for Erythroid Bursts in a Serum-Substituted System.”. Experimental Hematology 13 (10): 1073-9.

Lawler, J, T L Coetzer, J Palek, H S Jacob, and N Luban. 1985. “Sp Alpha I/65: A New Variant of the Alpha Subunit of Spectrin in Hereditary Elliptocytosis.”. Blood 66 (3): 706-9.

Dainiak, N, G Davies, M Kalmanti, J Lawler, and V Kulkarni. 1983. “Platelet-Derived Growth Factor Promotes Proliferation of Erythropoietic Progenitor Cells in Vitro.”. The Journal of Clinical Investigation 71 (5): 1206-14.

Margossian, S S, J W Lawler, and H S Slayter. 1981. “Physical Characterization of Platelet Thrombospondin.”. The Journal of Biological Chemistry 256 (14): 7495-500.

Lawler, J W, and H S Slayter. 1981. “The Release of Heparin Binding Peptides from Platelet Thrombospondin by Proteolytic Action of Thrombin, Plasmin and Trypsin.”. Thrombosis Research 22 (3): 267-79.

Matuszewska, Kathy, Madison Pereira, Duncan Petrik, Jack Lawler, and Jim Petrik. 2021. “Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake.”. Cancers 13 (17).